A wide-ranging group of chemicals generally referred to as “emerging contaminants” (ECs) have been found increasingly in waterways, drinking water systems, and upland environments, raising concerns about human and environmental safety. They include pharmaceuticals, chemicals in personal and consumer products, and industrial and agricultural chemicals.
Because knowledge about the toxicology, epidemiology, fate, and treatment of these compounds and the rules regulating them are evolving, our clients are faced with managing risks in a rapidly changing world.
We help our clients track EC science and regulations and develop effective risk management strategies to mitigate impacts from ECs on their businesses. We help our clients remain compliant with dynamic requirements and be good environmental and public health stewards.
MONTHLY PFAS ALERT NEWSLETTER
This groundbreaking newsletter covers the latest information on per- and polyfluoroalkyl substances (PFAS), including peer-reviewed publications, academic reports, media coverage, regulatory announcements, legislative decisions, and government assessments worldwide. Each edition contains hyperlinks to online source documents, and a synopsis of the publication and its relevance to stakeholders. As an added bonus, your subscription will also include breaking news updates for high priority alerts, library retrieval services for publications of interest, and access to Integral’s senior staff to discuss the potential relevance of information referenced in the alert to you or your organization.
For more information on the subscription, contact Janet Anderson at email@example.com.
PFAS Assessment and Management
Our team is at the forefront of technical and regulatory developments for PFAS. Our services include multimedia environmental sampling, field sampling programs and fate and transport assessment, toxicity evaluations, litigation support, product stewardship and registration support, treatment system design and engineering, and development of stakeholder and public communication materials.
We work with clients to design and implement strategies that reflect the latest technical knowledge and regulatory contexts. Our staff contribute to state-of-the-science approaches and research, participate on advisory boards, and lead workshops on topics involving ECs. We advise clients on ways to assess and minimize potential liabilities and offer insight on methods to conduct and streamline evaluations.
Toxicity Evaluations and Risk Assessment and Communication
We have unique experience assessing human risk related to ECs, including design and data analysis of human serum biomonitoring studies and assessing site-specific exposure compared to national baseline levels. Our key staff are nationally known for their work in the development of EC regulatory toxicity standards and regulatory programs, including PFAS, 1,4-dioxane and 1,2,3-TCP.
Our engineers have performed treatment technology evaluations for 1,4-dioxane, PFAS, 1,2,3-TCP, and other ECs. We are experienced in the evaluation of technology effectiveness, implementability, and cost. We have completed numerous remediation system designs, including those for potable water treatment systems.
FATE AND TRANSPORT
We extend our expertise in chemical fate and transport to a range of ECs, including PFAS, sulfolane, 1,4-dioxane, 1,2,3-TCP, organic acids, and other ECs to support litigation, assessment of human health risk issues, remedial investigations, and design of site-specific risk management and remediation strategies. Central to our approach is developing accurate and robust conceptual site models using multiple lines of evidence. Our approach allows us to negotiate remedies and risk mitigation plans based on defensible science.
PFAS Product Stewardship
We support manufacturers of PFAS and PFAS-enabled technology in evaluating and communicating the safety of their products to regulators, academics, the scientific community, and general public. Our staff assist with product and chemical registrations in the North American and EU regulatory arenas, as well as with the identification of key toxicological data gaps and technical issues related to product safety and potential use or end of lifecycle environmental concerns.
FEATURED STAFF MEMBER
Janet K. Anderson, Ph.D., DABT
Dr. Janet Anderson is a human health toxicologist and risk assessor with 15 years of experience providing toxicology expertise and consultation to federal agencies and industry. She specializes in risk communication, including the translation of toxicology data into state and federal regulatory policy decisions. Dr. Anderson performs critical reviews of federal and state risk assessment guidance and regulations.